Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.01 USD | +0.83% | -1.31% | -9.88% |
Mar. 22 | Gilead Sciences Completes $4.3 Billion Cymabay Acquisition | MT |
Mar. 22 | Gilead Sciences, Inc. completed the acquisition of CymaBay Therapeutics, Inc.. | CI |
- Stock
- Equities
- Stock Gilead Sciences, Inc. - Nasdaq
- News Gilead Sciences, Inc.